Spok Holdings to Release Q4 and Full Year 2025 Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 18 2026
0mins
Should l Buy SPOK?
Source: Newsfilter
- Earnings Release Schedule: Spok Holdings will announce its fourth quarter and full year 2025 operating results on February 25, 2026, after the U.S. market closes, providing critical operational data and future outlook for investors.
- Conference Call Details: Management will host a conference call and webcast at 5:00 p.m. ET on the same day, open to all interested parties, potentially including forward-looking information to help analysts and investors better understand the financial results.
- Participation Instructions: Participants are advised to dial in approximately ten minutes before the call starts, using the U.S. toll-free number 877-407-0890 or the international number +1-201-389-0918, ensuring smooth access to the meeting.
- On-Demand Access: For those unable to join the live call, an OnDemand version of the webcast will be available post-call, allowing investors to access relevant information at their convenience, thereby enhancing transparency and information accessibility.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SPOK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SPOK
Wall Street analysts forecast SPOK stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 12.140
Low
21.00
Averages
21.00
High
21.00
Current: 12.140
Low
21.00
Averages
21.00
High
21.00
About SPOK
Spok Holdings, Inc., through its wholly owned subsidiary Spok, Inc., is engaged in healthcare communications. The Company offers a focused suite of unified clinical communication and collaboration solutions that include call center applications, clinical alerting and notifications, one-way and advanced two-way wireless messaging services, mobile communications, and public safety solutions. Its one-way and advanced two-way wireless messaging services, including information services, throughout the United States. It also offers voice mail, personalized greetings, message storage and retrieval, equipment, maintenance plans and/or equipment loss protection to both one-way and two-way messaging subscribers. It also develops, sells and supports enterprise-wide systems for hospitals and other organizations needing to automate, centralize and standardize clinical communications. It offers its services and products to three major market segments: healthcare, government, and large enterprise.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several stocks, reflecting varying market outlooks that could influence investor decisions and market trends.
- Upgrades and Downgrades: While specific stock names are not mentioned, such rating changes typically lead to stock price volatility, prompting investors to pay close attention to these shifts for portfolio optimization.
- Market Reaction Expectations: The adjustments in analysts' ratings may trigger short-term market reactions, especially when investor sentiment towards specific stocks is sensitive, thereby impacting overall market sentiment.
- Enhanced Information Transparency: By providing a comprehensive view of analyst rating changes, investors can better understand market dynamics and make more informed investment decisions, thereby improving market transparency and efficiency.
See More
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting varying market perspectives on these firms.
- Market Dynamics: While specific company names are not mentioned, changes in analyst ratings typically influence investor decisions and can lead to price fluctuations in the affected stocks.
- Investor Focus: Investors considering buying TTD stock should pay attention to the latest insights from analysts to make more informed investment choices.
- Source of Information: This information is provided by Benzinga, highlighting the significance of analyst ratings in the market, and investors are encouraged to regularly check for updates.
See More
- Quarterly Dividend Declaration: Spok has declared a quarterly dividend of $0.3125 per share, consistent with previous distributions, reflecting the company's stable cash flow and profitability, which bolsters investor confidence.
- Dividend Yield: The forward yield of 9.08% makes this dividend attractive in the current market environment, potentially drawing in more investors seeking stable income.
- Payment Schedule: The dividend will be payable on March 31, with a record date of March 16 and an ex-dividend date also on March 16, ensuring shareholders receive their earnings promptly, thereby enhancing trust between the company and its shareholders.
- Financial Transparency: Spok provides a dividend scorecard and yield chart, further enhancing investors' understanding of the company's financial health, which promotes increased market interest in its stock.
See More
- Earnings Announcement Date: Spok is set to release its Q4 earnings on February 25 after market close, with market participants keenly awaiting the results to gauge the company's future growth potential.
- Stable Earnings Expectations: The consensus EPS estimate stands at $0.18, flat year-over-year, indicating a consistent profitability outlook for the company amidst market fluctuations.
- Slight Revenue Growth Forecast: The consensus revenue estimate is $34.6 million, reflecting a modest 2.1% year-over-year increase, suggesting that Spok is managing to sustain slight growth in a competitive environment.
- Historical Performance Review: Over the past year, Spok has only beaten EPS estimates 25% of the time and revenue estimates 50% of the time, indicating significant performance volatility that investors should consider when evaluating the stock.
See More
- Earnings Release Schedule: Spok Holdings will announce its fourth quarter and full year 2025 operating results on February 25, 2026, after the U.S. market closes, providing critical operational data and future outlook for investors.
- Conference Call Details: Management will host a conference call and webcast at 5:00 p.m. ET on the same day, open to all interested parties, potentially including forward-looking information to help analysts and investors better understand the financial results.
- Participation Instructions: Participants are advised to dial in approximately ten minutes before the call starts, using the U.S. toll-free number 877-407-0890 or the international number +1-201-389-0918, ensuring smooth access to the meeting.
- On-Demand Access: For those unable to join the live call, an OnDemand version of the webcast will be available post-call, allowing investors to access relevant information at their convenience, thereby enhancing transparency and information accessibility.
See More
- Earnings Release Schedule: Spok Holdings will announce its Q4 and full year 2025 financial results on February 25, 2026, after the U.S. market closes, reflecting the company's commitment to transparency and investor communication.
- Conference Call Details: Management will host a conference call and webcast at 5:00 PM ET on the same day to discuss the financial results, which is expected to include forward-looking information, thereby enhancing investor confidence.
- Client Communication Capacity: Spok Holdings sends over 70 million messages monthly through its solutions, demonstrating its leadership in healthcare communications and helping hospitals improve clinical workflows and administrative compliance.
- Platform Advantage: The Spok Care Connect® platform is widely relied upon by top hospitals to enhance patient outcomes, showcasing the strategic significance of the company's efforts to drive smarter and faster clinical communication in the healthcare sector.
See More







